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Abstract
The metabolic syndrome (MetS) is precisely defined and the cardiovascular risk 
associated with the clustering of its components has been demonstrated in adults. 
However, data on children and adolescents are still scarce, in part, due to difficulties in 
transposing the definition from adults. The identification of risk factors for the 
development of MetS at an early age is essential for prevention purposes with low-grade
inflammation acting as a determinant for the association among the MetS components. 
The aim of this study was to investigate the associations of the MetS with systemic 
markers of inflammation and ceruloplasmin in a population of adolescents. The present 
is a cross-sectional study whose sample population consisted of 976 adolescents, 13.2 ± 
1.2 years of age. Interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α) were 
determined by ELISA. High-sensitivity C-reactive protein (hs-CRP) was determined by 
a solid-phase chemiluminiscent immunometric assay. Ceruloplasmin was measured by 
immunoturbidimetry. MetS adolescents exhibited higher levels of TNF, IL-6, CRP 
and ceruloplasmin compared to non-MetS individuals. TNF, IL-6 and CRP showed 
strong correlations with the MetS components and insulin resistance but not relevant 
predictive values according to ROC curves (AUC values 0.544- 0.555). In contrast, 
ceruloplasmin only showed significant correlations in non-Mets individuals, but 
exhibited a very high predictive value (AUC=0.941, P < 0.001). The determination of 
serum ceruloplasmin in adolescents might be a useful tool to identify patients with the 
highest risk of future cardiovascular disease. 
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1. Introduction
The  metabolic  syndrome  (MetS)  is  defined  as  a  set  of  risk  factors  of  metabolic
precursors of atherosclerotic cardiovascular disease and type 2 diabetes mellitus (DM2)
(1-3). Until recently, the cluster of metabolic risk factors that are considered part of the
MetS had only been reported in adults, but increasingly numerous reports have shown
the presence of MetS during adolescence, probably driven by the high prevalence of
obesity from early age (4). According to the International Diabetes Federation (IDF),
MetS can be diagnosed in adolescent subjects when the following criteria are fulfilled: a
waist circumference ≥ 94 cm in boys and ≥80 cm in girls, together with two more risk
factors being these ones: fasting blood glucose levels 100-125 mg/dl, serum triglyceride
levels ≥150 mg/dl, HDL-cholesterol levels < 40 mg/dl in boys and < than 50 mg/dl in
girls and blood pressure ≥ 130/85 mmHg (5). 
The identification of risk factors for the development of MetS at an early age is
essential for prevention and early detection of the syndrome (6). In this regard, recent
studies  raised  the  importance  of  the  existence  of  a  chronic  state  of  low-grade
inflammation in these subjects, which appears to act as a determinant for the association
among the  components  of  the  MetS  (7).  This  low-grade  inflammation  seems to  be
expressed by alterations in serum levels of certain inflammation markers, such as C-
reactive  protein  (CRP),  interleukin  6  (IL-6),  tumor  necrosis  factor  alpha  (TNF-α).
Elevated levels of CRP are associated with increased expression and release of IL-6 by
adipose tissue (8) and can be considered independent predictors of future cardiovascular
events (9). In the case of TNF-α, despite being a classical marker in adults, for the
moment the evidence is not solid enough to support an association between serum levels
and  nutritional  status  of  in  adolescents  (10). More  recently, Aguilar  et  al.  (11)  and
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Giordano  et  al.  (12)  found  a  correlation  between  increased  serum  levels  of
ceruloplasmin, the main copper-carrying protein and one of the acute-phase reactants in
serum (13), and early development of cardiovascular disorders in obese adolescents.
There is evidence indicating that ceruloplasmin is associated with various components
of the MetS, like fasting glucose, triglycerides and HDL-cholesterol (14). 
Furthermore, the evidence suggests that insulin resistance (IR) is another key
factor in the development of MetS, as it is believed that a number of MetS components,
such as high blood pressure, dyslipidemia and glucose intolerance are caused by the IR
(15,16). However, studies on the relationship between IR and inflammatory markers are
limited to date, especially in adolescents. In this context, the objective of this study was
to investigate  the associations of  the MetS with the main markers  of inflammation,
especially ceruloplasmin, and IR in adolescents.  
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2. Methods
2.1 Data Source, Study Design and Recruitment
The  present  is  a  cross-sectional  study  whose  sample  population  consisted  of  976
adolescents, 13.2 ± 1.2 years of age. The subjects attended 18 schools in the provinces
of Granada and Almeria (south-east of Spain). The study was previously approved by
the Board of Education of the Andalusian Regional Government (Granada and Almeria
Delegations),  and also authorized by the school  principals.  The study, including the
model  of  informed  consent  used,  was  approved  by  the  Ethics  Committee  of  the
University of Granada. At the beginning of the study, an informed consent was obtained
from  the  subjects'  parents  or  guardians.  This  research  was  performed  in  strict
compliance  with  the  international  code  of  medical  ethics  established  by  the  World
Medical  Association  and  the  Declaration  of  Helsinki.  An  important  condition  for
inclusion in the study was that subjects had to be healthy and not have any type of
endocrine dysfunction or physical disorder. All students who did not meet these criteria
were not candidates to participate in the study.
2.2 Serum Biochemical Examination
At  8:00  A.M.  after  a  12-hour  overnight  fast,  10  ml  of  blood  was  extracted  by
venipuncture in the antecubital fossa of the right arm with a disposable vacuum blood
collection tube. In the four hours after the extraction, all samples were centrifuged at
1300g for 15 minutes (Z400 K, Hermle, Wehingen, Germany). The red blood cells were
thus separated and the serum was finally frozen at -80°C for its subsequent analysis.
Only  glucose  was  measured  immediately  after  collection.  IL-6  and  TNF-α  were
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determined by ELISA (Terumpo Corp, Newwark, USA; R&D Systems, Minneapolis,
USA). hs-CRP was determined by solid-phase chemiluminiscent immunometric assay.
Ceruloplasmin was measured by immunoturbidimetry (AU2700 biochemistry analyzer;
Olympus). Glucose was measured using a colorimetric enzymatic method (GOD-PAP
Method,  Human  Diagnostics,  Germany).  HbA1c  (glycosylated  hemoglobin)  was
measured  with  high-performance  liquid  chromatography  using  a  National
Glycohemoglobin Standardization Program certified automated analyzer (model HLC-
723 G7; Tosoh, Tokyo, Japan, intra-assay coefficient of variation <0.8 %, inter-assay
coefficient of variation <0.5 %), and was standardized according to the Diabetes Control
and  Complications  Trial.  Serum  insulin  was  determined  by  radioimmunoanalysis
(Insulin Kit, DPC, Los Angeles, EEUU). Insulin resistance was quantified with HOMA
(Homeostasis  Model  Assessment)  (17)  by  applying  the  following  formula:  fasting
glucose (mmol/L) x fasting insulin (mU/L)/ 22.5. 
2.3 Statistical Analyses
Continuous variables are expressed as mean and SD. CRP, TNF-α and IL-6 values were
log transformed to correct for non-normality. Normality was then assessed using the 
Kolmogorov-Smirnov's test. Statistical differences among Non-MetS and MetS boys 
and girls were assessed using ANOVA with post-hoc Tukey's test. Multivariate linear re-
gression analysis of HOMA-IR, the number of MetS components and inflammatory 
markers were performed adjusting by age, sex, BMI, weight at birth, smoking mother, 
maternal educational level and maternal obesity. Receiver-operator curves (ROC) were 
created to determine the predictive value for MetS of inflammation markers and the 
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MetS components. K-mean cluster analyses were performed to group cases according to
BMI and ceruloplasmin levels. Differences were considered significant at P < 0.05. 
Data were analyzed using SPSS software for Linux version 21.0 (IBM Corp, Amonk, 
USA).
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3. Results
Differences in markers of insulin resistance between boys and girls with or without a 
diagnosis of MetS are depicted in Table 1.  As expected, MetS subjects exhibited higher 
glucose, insulin, HBA1c and HOMA-IR values. Most of these parameters, except for 
glucose, also differed according to sex, but only in the non-MetS group. Insulin, 
HBA1c, and HOMA-IR values were higher in boys compared to girls. Likewise,  MetS 
boys and girls exhibited higher levels of all markers of inflammation studied (TNF, 
IL-6, CRP and ceruloplasmin) compared to non-MetS individuals (Table 2). Within the 
MetS group, boys presented higher plasma concentrations of TNF, IL-6, CRP but not
ceruloplasmin. 
Correlations among markers of inflammation and HOMA-IR are shown in Table
3. HOMA-IR values correlated with TNF, IL-6, CRP and ceruloplasmin in both 
MetS and non-MetS subjects with a high level of significance and independently of 
BMI. However, the level of significance was lower in boys than in girls suffering from 
MetS, which might be related to the lower number of subjects recruited in this group 
(n=16).  We also correlated the levels of inflammatory markers with the number of 
MetS components (serum glucose, triglyceride and HDL-cholesterol concentrations, 
blood pressure and waist circumference) (Table 4).  TNF, IL-6 and CRP correlated 
positively with the number MetS components in both MetS and non-MetS subjects. 
However, ceruloplasmin levels only showed significant correlations in non-MetS. No 
differences were observed regarding to sex. 
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In order to identify which of the MetS components had a higher predictive value 
for the syndrome, we performed a receiver operating characteristic (ROC) analysis 
(Figure 1A). As expected, waist circumference showed the highest area under the curve 
(AUC) value (0.970, P < 0.001), since it is a prerequisite for the diagnosis. The 
predictive value of blood pressure was also high (AUC=0.784, P < 0.001), but glucose, 
triglycerides and HDL-cholesterol exhibited a lower contribution to the prediction of 
MetS. The same analysis was performed for the markers of inflammation (Figure 1B).  
TNF, IL-6 and CRP showed very little predictive value for the MetS with very 
similar AUC values, ranging from 0.544 to 0.555. Remarkably, serum ceruloplasmin 
concentrations showed a high predictive value (AUC=0.941, P < 0.001), which was 
almost as high as that of waist circumference. The cut-off point for ceruloplasmin was 
established in 22.5 mg/dL, with a sensitivity of 90.9% and a specificity of 83.0%. The 
contingency analysis showed an asintotic significance of p<0.001 for the Chi-square test
and the linearity of the association. 
Tanking into account these results, and in order to visualize possible outliers that
would explain the sensitivity and specificity values, individual ceruloplasmin levels 
were plotted as a dot graph (Figure 2A). The graph clearly shows that dots are grouped 
into three categories of ceruloplasmin levels. The k-means cluster analysis confirmed 
the presence of three distinct groups that were associated with BMI (Figure 2B). In the 
first group (n=872) we found subjects with low BMI and ceruloplasmin levels (center 
located at 22 mg/dl for ceruloplasmin and 20.3 kg/m2 for BMI). The second group, 
consisted of subjects (n=28) with intermediate BMI and ceruloplasmin values (center 
located at 63 mg/dl for ceruloplasmin and 26.5 kg/m2 for BMI). And the third group 
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(n=76) showed high BMI and ceruloplasmin values (center located at 81 mg/dl for 
ceruloplasmin and 29.8 kg/m2 for BMI).
4. Discussion
A chronic state of low-grade inflammation appears to be determinant for the association 
among the MetS components. A number of inflammation markers have been associated 
with the presence of MetS (18) or with the different components that are used in the 
diagnosis of the MetS, i.e. triglycerides, HDL-c, glucose, blood pressure and waist 
circumference (7). The results of the present study support these observations in 
adolescents, since classical markers of inflammation (TNF, IL-6 and CRP) correlated
with the number of MetS components and with the HOMA index of insulin resistance. 
However, the most outstanding result was that ceruloplasmin showed the highest 
predictive value among markers of inflammation, being almost as good as that of the 
waist circumference, which is considered a prerequisite for the diagnosis of MetS. This 
might be of great importance for obese adolescents as ceruloplasmin has been suggested
as a potent marker of inflammation and insulin resistance in this population (15,16).
Adolescents with MetS showed higher levels of TNF, IL-6 and CRP 
compared to non-MetS individuals, which is in agreement with previous observations. 
Cytokines have been strongly associated with the MetS in the whole population (19)  
but also in the childhood. CRP has been related with MetS and its components in 
adolescents (20,21), being considered as a good marker of cardiovascular risk in this 
population (22). Makni et al. (23) compared a group of obese adolescents with and 
without MetS with a groups of controls, finding significant differences among the three 
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groups for TNF, IL-6 and CRP. Unfortunately, these authors did not include sex as a 
discriminatory variable. In the present study, sex appeared to be determinant for the 
presence of insulin resistance and inflammation, both in MetS and non-MetS 
adolescents. Boys showed higher HOMA-IR values in the group of non-MetS 
individuals and higher TNF, IL-6 and CRP values in the group of MetS. Serum 
ceruloplasmin concentrations resulted to be higher also in boys, but only in the non-
MetS group. Although there was a lack of significance in the MetS group, which might 
be related to the low number of subjects, sex might be an important characteristic when 
determining the presence of MetS. In adults, women with MetS exhibit higher levels of 
CRP (24,25)  but the reasons for the influence of sex remain unclear. It has been 
proposed that they might be associated with differences in body fat distribution (26) or 
hormone levels (27), but other authors found no differences in CRP levels between 
women with or without hormone replacement (24,25). In adolescents with MetS, 
González et al. (28) also observed higher levels of inflammatory markers in boys 
compared to girls, although differences were only significant for PAI-1. 
All markers of inflammation correlated strongly with the HOMA-IR and with 
the numbers of MetS components. Makni et al. (23) also reported significant 
correlations between TNF, IL-6 and CRP and the number of MetS components in 
obese adolescents with or without MetS, although they included up to three components
in the model, the minimum necessary for the classification of MetS, whereas we 
included the five components. In obese and normal-weight adolescents, Moon et al. (29)
found correlations between TNF and some, but not all, MetS components. In 
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particular, systolic blood pressure and fasting plasma concentrations did not correlate 
with TNF. 
Despite the lack of correlation between ceruloplasmin and the MetS, this marker 
of inflammation showed the strongest predictive value according to ROC analyses, 
being similar to that of waist circumference and better than other MetS components. In 
fact, glucose, triglycerides and HDL-c showed a low predictive value in adolescents 
when considered individually. In the present study we employed the IDF criteria for the 
diagnosis of MetS in adolescents (5). However, although the MetS in adults is precisely 
defined and the cardiovascular risk associated with the clustering of its components has 
been demonstrated (30), data on children and adolescents are still scarce. In part, this is 
due to difficulties encountered in transposing the definition from adults and, thus, the 
cluster of components (5). In this regard, ROC curves can be employed to discriminate 
between individuals with and without a certain disease, as they describe the 
performance of a model across the range of classification thresholds. The use of the 
AUC facilitates the task, as it aggregates performance across the entire range, giving 
higher the AUC values for variables with better predictive capacity. Interestingly, AUC 
values of ceruloplasmin (0.941) were similar to those of waist circumference (0.970) 
and considerably higher that other MetS components and markers of inflammation. 
Indeed, TNF, IL-6 and CRP, despite showing strong correlations with the 
components of MetS and insulin resistance, did not show relevant prediction values 
according to ROC curves. 
Ceruloplasmin, the main copper-carrying protein, is one of the acute-phase 
reactants and antioxidant proteins in serum, and has been associated with inflammatory 
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events occurring in atherosclerosis and diabetes mellitus (31). It is known that serum 
ceruloplasmin levels are elevated in subjects with MetS, as well as in subjects with Type
2 diabetes mellitus, and there is some evidence indicating associations with various 
components of the MetS, like fasting glucose, triglycerides and HDL-cholesterol (13). 
However, ceruloplasmin has not been independently associated with the other MetS 
components, that is, blood pressure (13) and central obesity (14), although patients with 
central obesity have characteristically higher ceruloplasmin serum levels, (14) due to 
overexpression of the protein (32). Therefore, the lack of association with some MetS 
components in previous studies might explain the lack of correlation of ceruloplasmin 
with the number of MetS components in the present one. 
As stated above, ceruloplasmin has been reported to strongly correlate with 
cardiovascular risk factors of lipid nature, particularly triglycerides (13, 33), which 
might be related to increased oxidative stress in the cell. Long-chain acyl-CoA derived 
from triglycerides can inhibit mitochondrial adenine nucleotide translocator, the rate-
limiting enzyme for exchange between mitochondrial adenosine triphosphate (ATP) and
cytosolic adenine diphosphate (ADP). When the mitochondrial ADP concentration is 
reduced, the proton gradient becomes higher, increasing the likelihood of accidental 
transfer of a single electron to oxygen, thereby increasing ROS generation in the cells. 
In this regard, it has been suggested that increased ceruloplasmin levels in MetS 
subjects might be a compensatory mechanism for increased oxidative stress associated 
with high serum triglycerides (13).
Nevertheless, and despite it has been proposed that serum ceruloplasmin level 
could be an independent risk factor for cardiovascular disease (34), the mechanism by 
which this protein is linked to cardiovascular disease is not established. Ceruloplasmin 
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might be involved in the inflammatory pathway linked to oxidative stress, in conditions 
promoting the copper release of the molecule, allowing the reaction of free copper with 
pro-oxidants factors (35). In contrast, others have proposed an antioxidant effect, as 
ceruloplasmin can reduce oxidative stress through its ferroxidase activity and inhibition 
of Fenton reaction, which uses the ferrous iron to generate reactive oxygen species (31).
Ceruloplasmin has an unspecific oxidase activity, participating in oxidation reactions 
with multiple organic and inorganic substrate, including Fe2+ ion, benzidine, p-
phenylendiamine or N-dimetilphenylendiamine. Currently, there is controversy on the 
association of iron concentrations in the body and its metabolism with the development 
of the MetS in both genders, both in adults and adolescents. Iron is usually considered 
as an independent factor for the development of MetS and, thus, not in all cases 
associated with ceruloplasmin levels (36-41).  
Another important finding of the present study was that ceruloplasmin levels 
were dependent on BMI. We found that ceruloplasmin levels were distributed into three 
groups according to ceruloplasmin levels and BMI, which suggests that BMI is the 
leading factor by which the MetS and ceruloplasmin are associated. In addition, they 
show that normal-weight subjects and obese subject had very different ceruloplasmin 
values, with overweight subjects falling within the three groups. In Spanish adolescents,
Wärnberg et al. (42) found significant correlations between BMI and WC with 
ceruloplasmin and, more recently, we reported associations between ceruloplasmin and 
BMI z-score, in non-obese and obese subjects (43).
The present study has some strengths and limitations. Among the strengths, the 
number of participants in this study is high. In addition, all participants belonged to the 
same geographical region, with similar culture, life-style and dietary habits, making the 
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sample more homogeneous. The recruitment was designed to select a representative 
sample of the entire population for the age groups studied in the region, for which we 
consider that the study is of great importance in epidemiological terms. Potential 
confounders such as age, sex, BMI, weight at birth, smoking mother, maternal 
educational level and maternal obesity were included in the regression model. However,
other potential confounders like the socioeconomic status or physical activity could not 
be included. Nevertheless, all participants were of a similar socioeconomic status and 
attended middle-class high-schools. 
In conclusion, adolescents diagnosed with the MetS showed a higher level of 
low-grade inflammation compared with non-MetS. Classical markers of inflammation 
(TNF, IL-6 and CRP) exhibited strong correlations with insulin resistance and the 
number of MetS components but a low predictive value for MetS. In contrast, serum 
ceruloplasmin concentration revealed as a potent predictor of MetS, although did not 
correlate with the number of MetS components in MetS subjects. In adolescents, we and
others have reported that ceruloplasmin correlates with indexes of obesity, such as BMI 
and the waist-to-hip ratio (11,42)  and with markers of insulin resistance (43). In the 
present study we give evidence for the first time that ceruloplasmin can provide an 
elevated predicted value for MetS in a large group of adolescents. Therefore, the 
determination of serum ceruloplasmin in adolescents with central obesity might be a 
useful tool to identify patients with the highest risk of future cardiovascular disease. 
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Figure 1. Receiver  operating characteristic  (ROC) curves  of  the components  of  the
metabolic syndrome (A) and inflammation markers (B) for prediction of MetS. AUC
values: IL-6: 0.555, TNF-, CRP: 0.548, ceruloplasmin: 0.941,  glucose: 0.548,
triglycerides: 0.538, HDL-cholesterol: 0.446, waist circumference: 0.970, systolic blood
pressure (SBP): 0.784 and diastolic blood pressure (DBP): 0.740.
Figure 2. Plasma ceruloplasmin concentrations in all participants (A) and according to
their BMI (B). 
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Table 1. Markers of insulin resistance in adolescents classified according to the absence (non MetS)
or presence (MetS) of the metabolic syndrome.
Non MetS MetS
Girls (n=489) Boys (n=441) Girls (n=30) Boys (n=16)
Mean SD Mean SD Mean SD Mean SD
Glucose (mg/dl) 84.4 27.4 84.6 29.1 98.2 45.0† 134.8 54.3*†††
Insulin (mU/ml) 18.5 5.9 20.2 9.1** 45.8 10.4††† 41.2 16.4†††
HBA1c  (%) 4.4 0.7 4.7 2.2** 7.9 2.4††† 7.8 2.8†††
HOMA-IR 3.9 1.9 4.2 2.0* 11.5 7.1††† 13.3 7.4†††
HBA1c, glycosylated hemoglobin; HOMA-IR, homeostasis model assessment of insulin resistance. 
*, P < 0.05 vs. girls; **, P < 0.01 vs. Girls; †, P < 0.05 vs. non MetS; †††, P < 0.001 vs. non MetS. 
Table 2.  Serum concentrations of inflammatory markers in adolescents classified according
 to the absence (non MetS) or presence (MetS) of the metabolic syndrome.
Non MetS MetS
Girls (n=489) Boys (n=441) Girls (n=30) Boys (n=16)
Mean SD Mean SD Mean SD Mean SD
TNF-α (pg/ml) 11.7 2.2 11.7 2.6 12.7 3.4† 16.4 3.5*†††
IL-6  (pg/ml) 12.7 2.1 12.7 2.5 13.7 3.4† 17.1 3.3*†††
CRP (mg/dl) 1.10 1.05 1.09 1.08 1.52 1.55† 3.30 1.88***†††
Ceruloplasmin (mg/dl) 23.9 10.9 26.8 16.3** 72.4 19.7††† 62.6 2.7†††
**, P < 0.01 vs. girls; ***, P < 0.001 vs. girls; †, P < 0.05 vs. non MetS; †††, P < 0.001 vs. non MetS.
Table 3. Correlation parameters of the serum concentration of inflammatory markers and 
HOMA-IR index in adolescents without (non MetS) or with (MetS) the metabolic syndrome. 
Non MetS MetS
Girls (n=489) Boys (n=441) Girls (n=30) Boys (n=16)
β P β P β P β P
TNF-α (pg/ml) 0.596 <0.001 0.487 <0.001 0.869 <0.001 0.660 0.050
IL-6 (pg/ml) 0.628 <0.001 0.436 <0.001 0.915 <0.001 0.579 0.019
CRP (mg/dl) 0.646 <0.001 0.490 <0.001 0.910 <0.001 0.545 0.029
Ceruloplasmin (mg/dl) 0.643 <0.001 0.763 <0.001 0.468 0.009 0.571 0.021
Regression co-efficient (β, (CI-95%)) is the effect size per increase in serum concentration 
of inflammatory markers and the HOMAIR index.
Table 4. Correlation parameters of the serum concentration of inflammatory markers 
and the number of metabolic syndrome components in adolescents without (non MetS) or
with (MetS) the metabolic syndrome.
Non MetS MetS
Girls (n=489) Boys (n=441) Girls (n=30) Boys (n=16)
β P β P β P β P
TNF-α (pg/ml) 0.612 < 0.001 0.679 < 0.001 0.886 < 0.001 0.850 < 0.001
IL-6 (pg/ml) 0.653 < 0.001 0.580 < 0.001 0.914 < 0.001 0.903 < 0.001
CRP (mg/dl) 0.695 < 0.001 0.689 < 0.001 0.941 < 0.001 0.903 < 0.001
Ceruloplasmin (mg/dl) 0.276 < 0.001 0.372 < 0.001 0.220 0.242 0.196 0.467
Regression co-efficient (β,  (CI-95%)) is the effect size per increase in serum concentration of inflammatory 
markers and the number of components of the metabolic syndrome. Components of the metabolic syndrome:
serum glucose, triglyceride and HDL-cholesterol concentrations, blood pressure and waist circumference.


